Page 99 - MaquetaFundCIEN-2019-ENG

5.4.
International Congress for Research and Innovation in Neurodegenerative Diseases (CIIIEN)
During 17th to 20st September 2019, it was held in Valencia, Spain the VII In- ternational Congress on Research and Innovation in Neurodegenerative Dis- eases (CIIIEN), promoted by the Queen Sofia Foundation in collaboration with CIEN Foundation and CIBERNED. The main objective of CIIIEN is providing a forum in which to share progress and information of interest on neurodegen- erative diseases among the scientific community.
The CIIIEN, created in 2013, definitely consolidates the two major scientific conferences on neurodegenerative diseases organized in Spain: the Interna- tional Symposium on Advances in Alzheimer’s Disease, promoted annually by the Queen Sofia Foundation and CIEN Foundation, and the CIBERNED Scientif- ic Forum, which brought together every year the research groups constitut- ing the CIBER in Neurodegenerative Diseases. Unifying both congresses was a first step in creating a new operating structure in the two main institu- tions devoted to research on neurological and neurodegenerative diseases in Spain: the CIEN Foundation and CIBERNED, both dependent on the Ministry of Science, Innovation and Universities through the Carlos III Institute of Health. This new structure seeks greater effectiveness and efficiency in research, fa- voring an interaction between the different research groups.
This seventh edition of CIIIEN was held at the Santiago Grisolía Auditorium in the Principe Felipe Science Museum and during three intense days of pres- entations and sharing of knowledge, gathered well over a hundred interna- tional experts. Organized by the Queen Sofia Foundation, CIEN Foundation (Foundation Center for Research in Neurological Diseases) and CIBERNED (Network Center for Biomedical Research in Neurodegenerative Diseases), the VII Congress CIIIEN is a forum for exchange on the main advances in re- search and treatment of Alzheimer’s, Parkinson’s, Huntington’s, and other neu- rodegenerative diseases.
The speakers included world leaders such as Agneta Nordberg (Karolinska Institute, Sweden), who in her Opening Lecture spoke about the importance of early diagnosis for the development of new treatments and preventive therapies. It also had the participation of Hilal Lashuel (Federal Polytechnic School of Lausanne, Switzerland), who presented his discoveries in the pro- cess of the formation of Lewy bodies in the formation of Parkinson’s, or Jorge J. Palop (Gladstone Institute of Neurological Diseases of San Francisco, Unit-
5. International relations
99